Kentucky Headlines: December 3, 2020 COVID-19 Update
A one-minute long news update, focused on COVID-19, airing before and after PBS NewsHour.
Risk of COVID-19 scams as vaccine approaches FDA approval
The coronavirus vaccine inching toward approval in the U.S. is desperately anticipated by weary Americans longing for a path back to normal life. But criminals are waiting, too, ready to use that desperation to their advantage, federal investigators say. A report from Associated Press and PBS NewsHour.
COVID-19’s Impact on Kentucky’s Health Care System
Renee Shaw and a panel of medical professionals discuss COVID-19's impact on Kentucky's hospitals, clinics, public health departments, and physicians. Guests include: Allison Adams, vice president for public policy at the Foundation for a Healthy Kentucky; Sarah Moyer, M.D., director of the Louisville Metro Department of Public Health and Wellness; and Jay Grider, D.O., Ph.D., chief physician executive at UK HealthCare.
Planning a Healthy and Nutritional Diet
Dr. Tuckson's guest is registered dietitian Beth Cecil, RDN, LD, manager of community wellness for Owensboro Health.
News of the Week: November 20, 2020
Bill Bryant and a panel of journalists discuss the week's news in the commonwealth, including new restrictions on businesses, schools, and gatherings from Gov. Andy Beshear in response to rising COVID-19 rates. Guests: John Cheves, Lexington Herald-Leader; Julia Fair, Cincinnati Enquirer; Melissa Patrick, Kentucky Health News; and Joe Sonka, Louisville Courier Journal.
Why we can’t have a normal Thanksgiving this year
An overwhelming surge of the coronavirus is afflicting the United States at the very moment that extended families are considering if, and how, they can gather for the holidays. Public health experts have three words for you: “don’t do it," warning that there is currently no risk-free way to spend time indoors with the loved ones who live outside your home. A report from Courtney Vinopal and Isabella Isaacs-Thomas of PBS NewsHour.
Two COVID-19 vaccine candidates may protect against the virus. Now what?
After months of clinical trials conducted at an unprecedented pace, two pharmaceutical companies in one week have released promising early data for a pair of vaccines designed to stop the coronavirus pandemic. But even as U.S. health officials predict that millions of Americans could begin to receive vaccinations as early as next month, more research must be done. A report from PBS NewsHour's Laura Santhanam.
The Immune System: Not Just Fighting Infections
Dr. Tuckson speaks with Barbara Nikolajczyk, Ph.D., a professor of Pharmacology and Nutritional Sciences at UK College of Medicine and associate director for Translational Research in Diabetes at the Barnstable Brown Diabetes Center.
Federal health officials announce COVID-19 vaccine agreement with pharmacies
On Thursday, federal health officials reached an agreement with pharmacies across the U.S. to distribute free coronavirus vaccines after they are approved and become available to the public. The agreement looks ahead to a time next spring when vaccines will start to become available beyond priority groups such as health care workers and nursing home residents. A report from the Associated Press via PBS NewsHour.
How a COVID vaccine might work — and the challenges of distributing it
As drug companies around the world rush to develop candidates for coronavirus vaccines, Pfizer announced encouraging early data from its own trials Monday. What do the preliminary results show, and even if they are borne out, what challenges remain with regard to production and distribution of the vaccine? Science correspondent Miles O’ Brien joins William Brangham to discuss.